Comment Letter | Payment Reimbursement and Managed Care

HFMA Comments on Requirements Related to Surprise Billing, Part II Interim Final Rule

Comment Letter | Payment Reimbursement and Managed Care

HFMA Comments on Requirements Related to Surprise Billing, Part II Interim Final Rule

HFMA  submitted comments to CMS on the Interim Final Rule with comment period implementing certain provisions of the No Surprises Act; Part II issued by the Department of Health and Human Services, the Department of the Treasury, the Department of Labor, and the Office of Personnel Management on October 7, 2021. The letter includes comments on specific proposals related to:

  • Provider/health plan negotiation process
  • Evaluation criteria for independent dispute resolution (IDR) entities
  • The anchoring benchmark of the IDR process is the qualifying payment amount (QPA) the health plan presents to arbitration
  • Good faith estimates for uninsured/self-pay patients
  • Uninsured/self-pay patient-provider dispute resolution threshold

Download the comment letter

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Payment Reimbursement and Managed Care

Fact Sheet | Payment Reimbursement and Managed Care

CY 2022 Physician Fee Schedule Final Rule Summary - Part I

HFMA presents a detailed summary of the final rule relating to the Medicare physician fee schedule for CY 2022 and other revisions to Medicare Part B policies.

Column | Cost Effectiveness of Health

Accelerated drug approvals present a mounting challenge to oncologists and raises concerns about cost effectiveness for health system finance leaders

In the past year, Americans have witnessed two extremes of the FDA’s accelerated approval process, exposing both profound strengths and worrisome weaknesses. Finance leaders should keep informed about new drug treatment options, their associated costs and efficacy and whether lower-cost alternatives that have the same efficacy are available so they can engage in meaningful conversations with clinicians about which options truly promote cost effectiveness of health.

Column | Healthcare Reform

Gail Wilensky: Physician payment and SDoH challenges loom large on nation’s path to value

Two primary obstacles stand in the way of the nation's ability to achieve cost-effective health and healthcare delivery: the slow transition to value-based payment by physicians and the need to address social determinants of health.

Fact Sheet | Payment Reimbursement and Managed Care

CY 2022 OPPS/ASC Final Rule Summary

HFMA presents a detailed summary of the CY 2022 OPPS and ASC payment system final rule, published by CMS.